Cargando…
l-Arginine intervention at hyper-acute phase protects the prolonged MRI abnormality in MELAS
Autores principales: | Kitamura, Miyuki, Yatsuga, Shuichi, Abe, Toshi, Povalko, Nataliya, Saiki, Reo, Ushijima, Kikumi, Yamashita, Yushiro, Koga, Yasutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971083/ https://www.ncbi.nlm.nih.gov/pubmed/27334908 http://dx.doi.org/10.1007/s00415-016-8069-4 |
Ejemplares similares
-
Developmental delay and failure to thrive in a 7-month-old baby boy with spontaneous transient Graves’ thyrotoxicosis: a case report
por: Yatsuga, Shuichi, et al.
Publicado: (2016) -
Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research
por: Koga, Yasutoshi, et al.
Publicado: (2018) -
The first Japanese case of central precocious puberty with a novel MKRN3 mutation
por: Nishioka, Junko, et al.
Publicado: (2017) -
Urinary stone in a 12-year-old adolescent with new-onset type 1 diabetes and
diabetic ketoacidosis
por: Ushijima-Fuchino, Kikumi, et al.
Publicado: (2022) -
Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
por: Ikawa, Masamichi, et al.
Publicado: (2020)